TERRABIOMEAI · MOLECULAR SIGNATURES

Pipeline

Signatures that hold up against what exists.

Three main therapeutic areas in human health, from blood to biopsy, and new areas in exploration. Every signature is tested against published or marketed tests.

3
therapeutic areas
13
head-to-heads with the market
9 / 13
matched or won
Lanes one area eachGates from discovery to measurement

Main areas

Where our signatures change a decision.

Programme details are shared under a confidentiality agreement.

Blood

Neurology

Select and monitor patients in neurology trials, including dementias.

External replication
Blood

Immunology and autoimmunity

Read treatment response and disease activity.

External replication
Blood · biopsy

Nephrology and transplantation

Kidney and lung transplant rejection, dosing by target engagement.

External replication
Exploration

New areas

Chronic inflammation, oncology and other therapeutic areas.

Discovery

Against the market

Every head-to-head, including the ones we lose.

On the same patients, our blindly discovered panel against the reference test for the indication. References anonymised: marketed products A to D or published academic signatures.

Right calls out of 100 · AUC × 100, 50 = chance○ reference ● TerraBiome
The toughest test

The panel is applied as is to patients from laboratories that were never used to build it. Each bar shows the performance gap with the reference test.

8

won, 1 tied

8

with entirely different genes

4

lost, 2 of them with our panel still above 95

7

clinical questions covered

TerraBiome signatures are research tools and are not diagnostic devices for routine medical use.

A biological question, a dataset, a molecule to understand?